Relmada Therapeutics names Bipin Dalmia as chief business officer
Go back to Relmada Therapeutics names Bipin Dalmia as chief business officer| (NASDAQ: RLMD) | Delayed: 4.43 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.43 | 52 Week High | $4.10 | |||
| Open | $4.43 | 52 Week Low | $0.87 | |||
| Day High | $4.43 | P/E | N/A | |||
| Day Low | $4.43 | EPS | $0.00 | |||
| Volume | 185 | |||||

